These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 33030504)

  • 1. US Food and Drug Administration Support for Oncology Drug Development During COVID-19.
    Kadakia KT; Pazdur R; Shah A
    JAMA Oncol; 2021 Jan; 7(1):27-28. PubMed ID: 33030504
    [No Abstract]   [Full Text] [Related]  

  • 2. The coronavirus outbreak could make it quicker and easier to trial drugs.
    Ledford H
    Nature; 2020 Jun; 582(7811):172. PubMed ID: 32504019
    [No Abstract]   [Full Text] [Related]  

  • 3. The Challenge and Management of Clinical Trials in Integrative Cancer during the COVID-19 Pandemic Worldwide.
    Yang G; Li M; Zhang H; Yang Y
    Integr Cancer Ther; 2021; 20():1534735421991218. PubMed ID: 33543656
    [No Abstract]   [Full Text] [Related]  

  • 4. The Day After COVID-19-Time to Rethink Oncology Clinical Research.
    Araujo DV; Watson GA; Siu LL
    JAMA Oncol; 2021 Jan; 7(1):23-24. PubMed ID: 32880604
    [No Abstract]   [Full Text] [Related]  

  • 5. In the COVID-19 era, let's keep an eye on clinical trials in Africa.
    Agoro R
    J Glob Health; 2020 Dec; 10(2):020312. PubMed ID: 33110516
    [No Abstract]   [Full Text] [Related]  

  • 6. Developing Safe and Effective Covid Vaccines - Operation Warp Speed's Strategy and Approach.
    Slaoui M; Hepburn M
    N Engl J Med; 2020 Oct; 383(18):1701-1703. PubMed ID: 32846056
    [No Abstract]   [Full Text] [Related]  

  • 7. [Fight against COVID-19: market overview and pipeline of ongoing trials].
    Pontremoli R; Richard G; Vuddamalay G; Groux N
    Med Sci (Paris); 2020 Dec; 36(12):1225-1232. PubMed ID: 33211647
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges in Drug Development Posed by the COVID-19 Pandemic: An Opportunity for Clinical Pharmacology.
    Venkatakrishnan K; Yalkinoglu O; Dong JQ; Benincosa LJ
    Clin Pharmacol Ther; 2020 Oct; 108(4):699-702. PubMed ID: 32356569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart Failure Collaboratory Statement on Clinical Trials in the Landscape of COVID-19.
    Abraham WT; Fiuzat M; Psotka MA; O'Connor CM
    JACC Heart Fail; 2020 May; 8(5):423-425. PubMed ID: 32354417
    [No Abstract]   [Full Text] [Related]  

  • 10. COVID-19 brings drug development to a halt.
    Mullard A
    Nat Rev Drug Discov; 2020 May; 19(5):298. PubMed ID: 32269308
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing Covid-19 Vaccines at Pandemic Speed.
    Lurie N; Saville M; Hatchett R; Halton J
    N Engl J Med; 2020 May; 382(21):1969-1973. PubMed ID: 32227757
    [No Abstract]   [Full Text] [Related]  

  • 12. Reverse Translation of US Food and Drug Administration Reviews of Oncology New Molecular Entities Approved in 2011-2017: Lessons Learned for Anticancer Drug Development.
    Faucette S; Wagh S; Trivedi A; Venkatakrishnan K; Gupta N
    Clin Transl Sci; 2018 Mar; 11(2):123-146. PubMed ID: 29266809
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparatory phase for clinical trials of COVID-19 vaccine in Nepal.
    Gupta GP; Shah Y; Pant DK; Lekhak S; Shahi R; Mandal A; Poudel P; Dumre SP; Pandey K; Pandey BD
    Hum Vaccin Immunother; 2021 Feb; 17(2):418-419. PubMed ID: 32966155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The COVID-19 pandemic].
    Bessis S
    Med Mal Infect; 2020 Sep; 50(8S):8S20-8S24. PubMed ID: 33357972
    [No Abstract]   [Full Text] [Related]  

  • 15. Lessons learned from the COVID-19 pandemic and its impact on bioanalysis and drug development.
    Wickremsinhe ER; Brockus CL; Murphy AT
    Bioanalysis; 2021 Aug; 13(15):1205-1211. PubMed ID: 34275332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The FDA's patient-focused drug development initiative.
    Kluetz PG; Bhatnagar V
    Clin Adv Hematol Oncol; 2021 Feb; 19(2):70-72. PubMed ID: 33596186
    [No Abstract]   [Full Text] [Related]  

  • 17. Proposals for managing patients with thoracic malignancies during COVID-19 pandemic.
    Girard N; Greillier L; Zalcman G; Cadranel J; Moro-Sibilot D; Mazières J; Audigier-Valette C; Bennouna J; Besse B; Cortot A; Couraud S; Duruisseaux M; Giroux-Leprieur E; Toffart AC; Westeel V; Wislez M;
    Respir Med Res; 2020 Nov; 78():100769. PubMed ID: 32563968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical Volume, Safety, Drug Administration, and Clinical Trials During COVID-19: Single-center Experience in Shanghai, China.
    Wang H; Wu J; Wei Y; Zhu Y; Ye D
    Eur Urol; 2020 Jul; 78(1):120-122. PubMed ID: 32349932
    [No Abstract]   [Full Text] [Related]  

  • 19. Conducting Clinical Research in the Era of Covid-19.
    Perez T; Perez RL; Roman J
    Am J Med Sci; 2020 Sep; 360(3):213-215. PubMed ID: 32690272
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical and Regulatory Aspects of Companion Diagnostic Development in Oncology.
    Jørgensen JT; Hersom M
    Clin Pharmacol Ther; 2018 Jun; 103(6):999-1008. PubMed ID: 29197081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.